Description
A vitamin K2 analog; increases osteocalcin, osteoprotegerin, and RANKL mRNA expression in osteoblastic MC3T3E cells; increases alkaline phosphatase activity and calcium content in femoral-metaphyseal tissues isolated from normal and skeletal-unloaded rats at 1 µM; inhibits aortic and myocardial calcification and decreases aortic alkaline phosphatase tissue concentrations in a rat model of extraosseous calcification at 100 µg/g diet; increases trabecular number, bone mineral density, and bone mineral content in a rat model of ovariectomy-induced bone loss
Formal name: 2-(-3,7,11,15,19,23,27-heptamethyloctacosa-2E,6E,10E,14E,18E,22E,26-heptaen-1-yl)-3-methylnaphthalene-1,4-dione
Synonyms: MK-7|Vitamin K2(35)|Vitamin MK-7
Molecular weight: 649
CAS: 2124-57-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Prenol Lipids||Research Area|Endocrinology & Metabolism|Bone Growth & Remodeling||Research Area|Endocrinology & Metabolism|Cofactors & Vitamins||Research Area|Lipid Biochemistry|Prenol Lipids